ArticleJournal of the American Chemical Society2026
Assessment of Complementary Catalysts in an Uncharted Enantioselective Reaction of Sulfondiimines.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enantioselective synthesis of sulfondiimidoyl fluoridesChemical science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Traditionally, many chemists turn to "privileged" catalyst scaffolds, which often demonstrate appreciable performance for a broad range of transformations. However, these structures can be challenging to modify, so complementary catalysts, such as peptides, are of interest. We simultaneously explored both peptidic and privileged cinchona catalysts for the asymmetric trifluoroacetylation of sulfondiimines (SDIs), an unexplored enantioselective reaction. The resultant acylated SDIs can enable access to a broad range of enantioenriched sulfur(VI) products for potential applications as bioisosteres. A significant challenge facing the establishment of an enantioselective variant of this reaction is that the background reaction has a high rate of reactivity, achieving 70% conversion in just 1 h at -78 °C. Nonetheless, we identified both a peptide and a cinchona alkaloid featuring kinetic profiles that outcompete this extremely fast background reactivity by an order of magnitude. Substrate scope was profiled using an algorithmic strategy followed by a comparison of statistical models relating substrate molecular descriptors and ΔΔ
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.